Skip to main content
. 2009 Apr 24;467(12):3239–3248. doi: 10.1007/s11999-009-0846-2

Table 3.

Clinical studies on the application of BMP-7, ABG, or their combination for the treatment of long-bone fracture nonunions

Study (year) Type of study, LOE Anatomic site of nonunions Number of cases Age (years)* Time from injury (months)* Number of previous operations* Union rates Time to nonunion healing (months)* Reoperations
Souter [42] (1969) Retrospective observational (ABG), IV Tibia, femur, humerus, forearm 102 ABG 40 (15–77) 6 (2–84) NA 86% 4 NA
Friedlaender et al. [18] (2001) Prospective randomized, controlled (BMP-7 versus ABG), II Tibia 63 BMP-7 Median 38 ± 16 Median 27 ± 26 NA 81% 9 5%
61 ABG Median 34 ± 14 Median 33 ± 46 85% 10%
Babhulkar and Pande [3] (2005) Retrospective observational (ABG), IV Tibia, femur, humerus, forearm atrophic 52 ABG NA NA NA 77% 6 (4–8) NA
Ronga et al. [38] (2006) Retrospective observational (BMP-7), IV Tibia, femur, humerus 38 BMP-7 42.2 (15–78) 27.3 ± 39.9 1.6 ± 0.8 86% 7.9 (2–21) 15.2%
50 BMP-7 + ABG 31.2 ± 59.0 2.7 ± 2.1 86.8%
Calori et al. [9] (2006) Prospective randomized, controlled (BMP-7 versus PRP), II–III Tibia, femur, humerus, forearm 16 BMP-7 47.4 ± 2.56 15.2 ± 2.46 2.5 ± 0.57 94% Radiographic 8 ± 0.43 6.2%
Zimmermann et al. [55] (2007) Prospective comparative (BMP-7 versus ABG), III Tibia 18 BMP-7 44 (19–68) 11 (NA) 4 (NA) 94.5% 5 5.5%
8 BMP-7 + ABG 87.5% 12.5%
82 ABG 0 72% 31.7%
Kanakaris et al. [27] (2008) Prospective observational (BMP-7), IV Tibia 43 BMP-7 42.6 (19–78) 23 (9–317) 2 (0–11) 89.7% 6.5 (3–15) 6%
25 BMP-7 + ABG
Giannoudis et al. [current study] Prospective observational (BMP-7 + ABG), IV Tibia, femur, humerus 45 BMP-7 + ABG Median 43 (19–76) Median 30 (6–312) Median 2 (1–7) 100% Median 6 (4–16) 0%

* Values are expressed as mean (or median as noted) ± standard deviation with range in parentheses; BMP-7 = bone morphogenetic protein-7; ABG = autologous bone graft; LOE = level of evidence; NA = not available.